Prebiotics and reduction of risk of carcinogenesis: Review of experimental and human data

Handbook of Prebiotics

Volumn , Issue , 2008, Pages 295-328

  Klinder, Annett ^a   Glei, Michael ^b   Pool Zobel, Beatrice L ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967099071     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (141)

1. Boyle, P. and Langman, J.S., ABC of colorectal cancer: Epidemiology, Br. Med. J, 321, 805,2000.
2. Reddy, B.S., Diet and colon cancer: Evidence from human and animal model studies, in Diet, Nutrition, and Cancer: A Critical Evaluation Volume I. Macronutrients and Cancer, Reddy, B.S. and Cohen, L.A., Eds., CRC Press Inc., Boca Raton, 1986, 48.
3. Schatzkin, A. et al., Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group, N. Engl. J. Med., 342,1149, 2004.
4. Pietinen, P. et al., Diet and risk of colorectal cancer in a cohort of Finnish men, Cancer Causes Control, 10, 387, 1999.
5. Fuchs, C.S. et al., Dietary fiber and the risk of colorectal cancer and adenoma in women, N. Engl. J. Med., 340, 169, 1999.
6. Bingham, S.A. et al., Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): An observational study, Lancet, 361, 1496, 2003.
7. Hartman, T.J. et al., Does nonsteroidal anti-inflammatory drug use modify the effect of a low-fat, high-fiber diet on recurrence of colorectal adenomas? Cancer Epidemiol. Biomarkers Prev., 14, 2359, 2005.
8. Jacobs, E.T. et al., Fiber, sex and colorectal adenoma: Results of a pooled analysis, Am. J. Clin. Nutr., 83, 343, 2006.
9. Lin, J. et al., Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States), Cancer Causes Control, 16, 225,2005.
10. Saura-Calixto, F. et al., In vitro determination of the indigestible fraction in foods: An alternative to dietary fiber analysis, J. Agric. Food Chem., 48, 3342, 2000.
11. da S Queiroz-Monici, K. et al., Bifidogenic effect of dietary fiber and resistant, Nutrition, 21, 602, 2005.
12. Costabile, A. et al., Whole grain breakfast cereals have a prebiotic effect on the human gut microbiota—a double-blind, placebo-controlled, cross-over study, 29,1-11, 2007.
13. Van Loo, J. et al., On the presence of inulin and oligofructose as natural ingredients in the Western diet, Crit. Rev. Food Sci. Nutr., 35, 525, 1995.
14. Tungland, B.C. and Meyer, D., Nondigestible oligo- and polysaccharides (dietary fibre): Their physiology and role in human health and food, Comprehensive Reviews in Food Science and Food Safety, 3, 73, 2002.
15. Jacobsen, H. et al., Carbohydrate digestibility predicts colon carcinogenesis in azoxymethane-treated rats, Nutr. Cancer, 55, 163,2006.
16. Femia, A.P. et al., Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats, Carcinogenesis, 23,1953, 2002.
17. Verghese, M. et al., Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats, J. Nutr., 132, 2809,2002.
18. Gallaher, D.D. et al., Probiotics, cecal microflora, and aberrant crypts in the rat colon, J. Nutr., 126, 1362, 1996.
19. Bolognani, F. et al., Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats, Eur. J. Nutr., 40, 293, 2001.
20. Poulsen, M., Molck, A.M. and Jacobsen, B.L., Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats, Nutr. Cancer, 42,194,2002.
21. Caderni, G. et al., Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: Correlation with carcinogenesis, Cancer Res., 63, 2388, 2003.
22. Reddy, B.S., Hamid, R. and Rao, C.V., Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition, Carcinogenesis, 18,1371, 1997.
23. Buddington, K.K., Donahoo, J.B. and Buddington, R.K., Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers, J. Nutr., 132, 472, 2002.
24. Verghese, M. et al., Inhibitory effects of non digestible carbohydrates of different chain lengths on AOM induced abberant crypt foci in Fisher 344 rats, Proceedings of the Second Annual AACR International Conference "Frontiers in Cancer Prevention Research" Phoenix, Poster B186, 73, 2003.
25. Pierre, F. et al., Short chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut associated lymphoid tissue in Min mice, Cancer Res., 57,225, 1997.
26. Van Loo, J. et al., Prebiotic oligofructose-enriched chicory inulin combination with probiotics in the prevention of colon cancer in experimental models and human volunteers, AgroFood Industry Hi-Tech, 16, 6,2005.
27. Min mice: Relation to p-catenin and PKC isozymes, Carcinogenesis, 21,1167, 2000.
28. Kettunen, H.L., Kettunen, A.S.L. and Rautonen, N.E., Intestinal immune response in wild-type and APC+/Min mouse, a model for colon cancer, Cancer Res, 63, 5136, 2003.
29. Pajari, A.M. et al., Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice, Int. J. Cancer, 106, 653, 2003.
30. Misikangas, M. et al., Promotion of adenoma growth by dietary inulin is associated with cyclin D1 and decrease in adhesion proteins in Min/+ mice mucosa, J. Nutr. Biochem., 16, 402,2005.
31. Ellegard, L., Andersson, H. and Bosaeus, I., Inulin and oligofructose do not influence the absorption of cholesterol, or excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects, Eur. J. Clin. Nutr, 51, 1, 1997.
32. Molis, C. et al., Digestion, excretion, and energy value of fructooligosaccharides in healthy humans, Am. J. Clin. Nutr., 64, 324, 1996.
33. Bouhnik, Y. et al., The capacity of nondigestible carbohydrates to stimulate fecal bacteria in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study, Am. J. Clin. Nutr., 80, 1658, 2004.
34. Silvi, S. et al., Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with faeces from Italian and UK donors, J. Appl. Microbiol., 86, 521,1999.
35. Brown, I. et al., Fecal numbers of bifidobacteria are higher in pigs fed Bifidobacterium longum with a high amylose cornstarch than with a low amylose cornstarch, J. Nutr., 127,1822,1997.
36. Kleessen, B. et al., Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats, J. Anim. Sci., 75, 2453, 1997.
37. Wang, X. et al., Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amylomaize) starch granules, J. Appl. Microbiol., 93, 390, 2002.
38. Le Leu, R.K. et al., A synbiotic combination of resistant starch and Bifidobacterium lactis facillitates apoptotic deletion of carcinogen-damaged cells in rat colon, J. Nutr, 135, 996, 2005.
39. Ahmed, R., Segal, I. and Hassan, H., Fermentation of dietary starch in humans, Am. J. Gastroenterol., 95, 1017, 2000.
40. Burn, J. et al., Diet and cancer prevention: The Concerted Action Polyp Prevention (CAPP) Studies, Proc. Nutr. Soc., 57,183, 1998.
41. Young, G.P. et al., Wheat bran suppresses potato starch-potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model, Gastroenterology, 110, 508.1996.
42. Coleman, L.J. et al., A diet containing a-cellulose and fish oil reduces aberrant crypt foci formation and modulates other possible markers for colon cancer risk in azoxymethane-treated rats, J. Nutr., 132, 2312, 2002.
43. Williamson, S.L. et al., Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 month, Carcinogenesis, 20, 805,1999.
44. Sakamoto, J. et al., Comparison of resistant starch with cellulose diet on 1,2-dimethylhydrazine-induced colonic carcinogenesis in rats, Gastroenterology, 110, 116. 1996.
45. Maziere, S. et al., Effects of resistant starch and/or fat-soluble vitamins A and E on the initiation stage of aberrant crypts in rat colon, Nutr. Cancer, 31,168,1998.
46. Cassand, P. et al., Effects of resitant starch- and vitamin-A-supplemented diets on the promotion of precursor lesions of colon cancer in rats, Nutr. Cancer, 27, 53, 1997.
47. Perrin, P. et al., Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats, Gut, 48, 53,2001.
48. Nakanishi, S. et al., Effects of high amylose maize starch and Clostridium butyricum on metabolism in colonic microbiota and formation of azoxymthane-induced aberrant crypt foci in the rat colon, Microbiol. Immunol., 47, 951, 2003.
49. Bauer-Marinovic, M. et al., Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon, Carcinogenesis, 27,1849, 2006.
50. Thorup, I., Meyer, O. and Kristiansen, E., Effect of potato starch, cornstarch and sucrose on aberrant crypt foci in rats exposed to azoxymethane, Anticancer Res., 15,2101, 1995.
51. Samelson, S.L., Nelson, R.L. and Nyhus, L.M., Protective role of faecal pH in experimental colon carcinogenesis, J. R. Soc. Med., 78,230, 1985.
52. Hennigan, T.W. et al., Protective role of lactulose in intestinal carcinogenesis, Surg. Oncol., 4, 31,1995.
53. Challa, A. et al., Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats, Carcinogenesis, 18, 517, 1997.
54. Wijnands, M.V.W. et al., A comparison of the effects of dietary cellulose and fermentable galacto-oligosaccharide, in a rat model of colorectal carcinogenesis: Fermentable fibre confers greater protection than non-fermentable fibre in both high and low fat backgrounds, Carcinogenesis, 20, 651, 1999.
55. Wijnands, M.V.W. et al., Effect of dietary galacto-oligosaccharides on azoxymethane-induced abberant crypt foci and colorectal cancer in Fischer 344 rats, Carcinogenesis, 22,127, 2001.
56. Gallaher, D.D. and Khil, J., Effects of synbiotics on colon carcinogenesis in rats, J. Nutr., 129,1483S, 1999.
57. Hsu, C.-K. et al., Xylooligosaccharides and fructooligosaccharides affect the intestinal microflora and precancerous colonic lesion development in rats, J. Nutr., 134, 1523, 2004.
58. Koo, M. and Rao, A.V., Long-term effect of bifidobacteria and neosugar on precursor lesions of colonic cancer in CF1 mice, Nutr. Cancer, 16,249, 1991.
59. Rowland, I.R. et al., Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats, Carcinogenesis, 19,281,1998.
60. Verghese, M. et al., Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats, J. Nutr., 132, 2804, 2002.
61. Hague, A. et al., Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53—independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer, Int. J. Cancer, 55, 498, 1993.
62. Waf/CIP protein in human colonic adenocarcinoma cells independently of p53 status, Nutr. Cancer, 46, 202, 2003.
63. Caderni, G. et al., Slow-release pellets of sodium butyrate do not modify azoxymethane (AOM)-induced intestinal carcinogenesis in F344 rats, Carcinogenesis, 22, 525,2001.
64. Wong, C.S. et al., The influence of specific luminal factors on the colonic epithelium: High-dose butyrate and physical changes suppress early carcinogenic events in rats, Dis. Colon Rectum, 48, 549,2005.
65. Compher, C.W. et al., Wheat bran decreases aberrant crypt foci, preserves normal proliferation, and increases intraluminal butyrate levels in experimental colon cancer, J. Parenter. Enteral. Nutr., 23, 269, 1999.
66. McIntyre, A., Gibson, P.R. and Young, G.P., Butyrate production from dietary fibre and protection against large bowel cancer in a rat model, Gut, 34,386,1993.
67. McIntosh, G.H., Royle, PJ. and Pointing, G., Wheat aleurone flour increases cecal ß-glucuronidase activity and butyrate concentration and reduce colon adenoma burden in azoxymethane treated rats, J. Nutr., 131, 127,2001.
68. Wijnands, M.V.W. et al., Do abberant crypt foci have predictive value for the occurrence of colorectal tumours? Potential of gene expression profiling in tumours, Food Chem. Toxicol., 42,1629,2004.
69. Magnuson, B.A., Carr, I. and Bird, R.P., Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid, Cancer Res., 53, 4499, 1993.
70. Davies, M.J. et al., Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats, Carcinogenesis, 20, 927,1999.
71. Hughes, R. and Rowland, I.R., Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon, Carcinogenesis, 22, 43, 2001.
72. Le Leu, R.K. et al., Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium, and lumenal contents in rats, Carcinogenesis, 24, 1347,2003.
73. Mentschel, J. and Claus, R., Increased butyrate formation in the pig colon by feeding raw potato starch leads to a reduction of colonocyte apoptosis and a shift to the stem cell compartment, Metabolism, 52, 1400, 2003.
74. Madsen, K., Probiotics and the immune response, J. Clin. Gastroenterol., 40,232, 2006.
75. Matsuzaki, T., Immunmodulation by treatment with Lactobacillus casei strain Shirota, Int. J. Food Microbiol., 41,133, 1998.
76. Pierre, F. et al., T cell status influences colon tumor occurence in Min mice fed short chain fructo-oligosaccharides as a diet supplement, Carcinogenesis, 20, 1953, 1999.
77. Bassonga, E. et al., Cytokine mRNA expression in mouse colon: IL-15 mRNA is overexpressed and is highly sensitive to a fibre-like dietary component (short-chain fructo-oligosaccharide) in an APC gene manner, Cytokine, 14, 243, 2001.
78. Forest, V. et al., Large intestine intraepithelial lymphocytes from APC+/+ and APC+/Min mice and their modulation by indigestible carbohydrate: The IL-15/IL-15R alpha complex and CD4+ CD25+ T cell are main targets, Cancer Immunol. Immunother., 54, 78, 2005.
79. Roller, M. et al., Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus andBifidobacterium lactis, Br. J. Nutr., 92, 931,2004.
80. Rafter, J. et al., Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients, Am. J. Clin. Nutr., 85, 488, 2007.
81. Gorbach, S.L. and Goldin, B.R., The intestinal microflora and the colon cancer connection, Rev. Infect. Dis., 12, S252-S261,1990.
82. Nakamura, J. et al., Comparison of four microbial enzymes in clostridia and, microbol Immunol. 46, 487, 2002.
83. Rowland, I.R. and Tanaka, R., The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora, J. Appl. Bacteriol., 74, 667, 1993.
84. Buddington, R.K. et al., Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects, Am. J. Clin. Nutr., 63, 709, 1996.
85. Hylla, S. et al., Effects of resistent starch on the colon in healthy volunteers: Possible implications for cancer prevention, Am. J. Clin. Nutr., 67, 136, 1998.
86. Ohta, A. et al., A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice, J. Nutr., 132, 2048, 2002.
87. Djouzi, Z. and Andrieux, C., Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora, Br.J. Nutr, 78,313,1997.
88. Bouhnik, Y. et al., Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans, Nutr. Cancer, 26,21,1996.
89. Kleessen, B. et al., Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons, Am. J. Clin. Nutr., 65, 1397, 1997.
90. Ridlon, J.M., Kang, D. and Hylemon, P.B., Bile salt biotransformation by human intestinal bacteria, J. Lipid Res., 47, 241, 2006.
91. Takahashi, T. and Morotomi, M., Absence of cholic acid 7a-dehydroxylase activity in the strains of Lactobacillus and Bifidobacterium, J. Dairy Sci., 77, 3275, 1994.
92. Flynn, C. et al., Deoxycholic acid promotes the growth of colonic aberrant crypt foci, Mol. Carcinog., 46, 60,2007.
93. Glinghammar, B. and Rafter, J., Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells, Gastroenterology, 120, 401,2001.
94. Venturi, M. et al., Genotoxic activity in human faecal water and the role of bile acids: A study using the alkaline comet assay, Carcinogenesis, 18,2353, 1997.
95. Kamano, T. et al., Ratio of primary and secondary bile acids in feces: Possible marker for colorectal cancer?, Dis. Colon Rectum, 42, 668,1999.
96. Jacobasch, G. et al., Hydrothermal treatment of Novelose 330 results in high yields of resistant starch type 3 with beneficial prebiotic properties and decreased secondary bile acid formation in rats, Br. J. Nutr., 95,1063, 2006.
97. van Berge Henegouwen, G.P., van der Werf, S.D. and Ruben, A.T., Effect of long term lactulose ingestion on secondary bile salt metabolism in man: Potential protective effect of lactulose in colonic carcinogenesis, Gut, 28, 675, 1987.
98. Nagengast, F.M. et al., Inhibition of secondary bile acid formation in the large intestine by lactulose in healthy subjects of two different age groups, Eur. J. Clin. Nutr., 18, 56,1988.
99. van Dokkum, W. et al., Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects, Eur. J. Clin. Nutr., 53, 1, 1999.
100. Boutron-Ruault, M.C. et al., Effects of a 3-mo comsumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas, Nutr. Cancer, 53,160, 2005.
101. Bouhnik, Y. et al., Lactulose ingestion increases faecal bifidobacterial counts: A randomised double-blind study in healthy humans, Eur. J. Clin. Nutr., 58, 462,2004.
102. Brighenti, F. et al., Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers, Eur.J. Clin. Nutr., 53, 726, 1999.
103. Alles, M.S. et al., Effects of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer, Am. J. Clin. Nutr., 69, 980,1999.
104. Osswald, K. et al., Inter- and Intra-individual variation of faecal water— genotoxicity in human colon cells, Mutat. Res., 472, 59, 2000.
105. Rieger, M.A. et al., Diets high in fat and meat, but low in fiber increase the genotoxic potential of fecal water, Carcinogenesis, 20,2317, 1999.
106. Oberreuther-Moschner, D. et al., Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates DNA-damage inducing potential of human faecal water in HT29clone19A cells, Br. J. Nutr., 91, 925, 2004.
107. Klinder, A. et al., Faecal water genotoxicity is predictive of tumor preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis) and their synbiotic combination, Nutr. Cancer, 49, 144, 2004.
108. Hughes, R., Pollock, J.R. and Bingham, S., Effect of vegetables, tea, and soy on endogenous N-nitrosation, fecal ammonia, and fecal water genotoxicity during a high red meat diet in humans, Nutr. Cancer, 42, 70, 2002.
109. Reddy, B.S., Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth, J. Nutr., 129,1478S, 1999.
110. Sengupta, S., Muir, J.G. and Gibson, P.R., Does butyrate protect from colorectal cancer?, J. Gastroenterol. Hepatol., 21,209, 2006.
111. Wong, J.M. et al., Colonic health: Fermentation and short chain fatty acids, J. Clin. Gastroenterol., 40, 235, 2006.
112. Lupton, J.R., Microbial degaradation products influence colon cancer risk: The butyrate controversy, J. Nutr., 134, 479,2004.
113. Basson, M.D., Emenaker, N.J. and Hong, F., Differential modulation of human (Caco-2) colon cancer cell line phenotype by short chain fatty acids, Proc. Soc. Exp. Biol. Med, 217,476,1998.
114. Comalada, M. et al., The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype, J. Cancer Res. Clin. Oncol, 132,487, 2006.
115. Inagaki, A. and Sakata, T., Dose-dependent stimulatory and inhibitory effects of luminal and serosal n-butyric acid on epithelial cell proliferation of pig distal colonic mucosa, J. Nutr. Sci. Vitaminol., 51, 156, 2005.
116. Ebert, M.N. et al., Expression of Glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate, Carcinogenesis, 24, 1637, 2003.
117. Pool-Zobel, B.L. et al., Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics, Carcinogenesis, 26, 1064, 2005.
118. Sauer, J., Richter, K.K. and Pool-Zobel, B.L., Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells, J. Nutr. Biochem., 18, 736,2007.
119. Abrahamse, S.L., Pool-Zobel, B.L. and Rechkemmer, G., Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration in isolated rat colon cells, Carcinogenesis, 20, 629, 1999.
120. Ebert, M.N. et al., Butyrate-induces glutathione S-transferase in human colon cells and protects from genetic damage by 4-hydroxynonenal, Nutr. Cancer, 41, 156,2001.
121. Wattenberg, L.W., Inhibition of carcinogenesis by minor dietary constituents, Cancer Res., 52, 2085, 1992.
122. Johnson, I.T., Williamson, G. and Musk, S.R.R., Anticarcinogenic factors in plant foods: A new class of nutrients? Nutr. Res. Rev., 7, 175, 1994.
123. Beyer-Sehlmeyer, G. et al., Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources, Br. J. Nutr., 90, 1057,2003.
124. Klinder, A. et al., Gut fermentation products of inulin-derived prebiotics beneficially modulate markers of tumour progression in human colon tumour cells, International Journal of Cancer Prevention, 1, 19, 2004.
125. Glei, M. et al., Both wheat (Triticum aestivum) bran arabinoxylans and gut floramediated fermentation products protect human colon cells from genotoxic activities of 4-hydroxynonenal and hydrogen peroxide, J. Agric. Food Chem., 54, 2088, 2006.
126. Sauer, J., Richter, K.K. and Pool-Zobel, B.L., Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells, Br. J. Nutr., 97, 928, 2007.
127. Commane, D.M. et al., Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon, Nutr. Cancer, 51,102,2005.
128. Ponz de Leon, M. and Roncucci, L., Chemoprevention of colorectal tumors: Role of lactulose and of other agents, Scand. J. Gastroenterol. Suppl., 222, 72,1997.
129. Mathers, J. et al., Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The concerted action polyp prevention (CAPP) 1 study, Proc. Nutr. Soc., 62, 51, 2003.
130. CAPP1 abstract. http://www.ncl.ac.uk/ihg/about/capp1abstract. 2007.
131. Glei, M. et al., Assessment of DNA damage and its modulation by dietary and genetic factors in smokers using the Comet assay: A biomarker model, Biomarkers, 10, 203, 2005.
132. Olano-Martin, E., Gibson, G.R. and Rastall, R.A., Comparison of the in vitro bifidogenic properties of pectins and pectic-oligosaccharides, J. Appl. Microbiol., 93, 505, 2002.
133. Harris, P.J. et al., The adsorption of heterocyclic aromatic amines by model dietary fibres with contrasting compositions, Chem. Biol. Interact., 100, 13,1996.
134. Ferguson, L.R. et al., The adsorption of a range of dietary carcinogens by alphacellulose, a model insoluble dietary fiber, Mutat. Res., 319, 257, 1993.
135. Cohen, L.A. et al., Wheat bran and psyllium diets: Effects on N-methylnitrosourea-induced mammary tumorigenesis in F344 rats, J. Natl. Cancer Inst, 88, 899,1996.
136. Cohen, L.A., Dietary fiber and breast cancer, Anticancer Res., 19, 3685, 1999.
137. World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington DC: American Institute for Cancer Research, 1997.
138. Van Loo, J.A., Prebiotics promote good health: The basis, the potential, and the emerging evidence, J. Clin. Gastroenterol., 38, S70,2004.
139. Bibby, M.C. and Double, J.A., Flavone acetic acid—from laboratory to clinic and back, Anticancer Drugs, 4, 3, 1993.
140. Ferguson, L.R., Chavan, R.R. and Harris, P. J., Changing concepts of dietary fiber: Implications for carcinogenesis, Nutr. Cancer, 39, 155, 2001.
141. Rao, C.V. et al., Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin, Carcinogenesis, 18, 1815, 1997.